EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.21.89 | Acute Lung Injury |
15516485 |
Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. |
causal interaction
unassigned |
3
0 |
| 3.4.21.89 | Brain Injuries, Traumatic |
24201023 |
Interest of workplace support for returning to work after a traumatic brain injury: a retrospective study. |
unassigned |
0 |
| 3.4.21.89 | Carcinoma |
404821 |
[Histochemical and ultrastructural investigations on invasive growth of tumour. I. Enzyme-histochemical investigations (author's transl)] |
unassigned |
0 |
| 3.4.21.89 | Cholangitis |
10689902 |
[An extremely elderly patient with choledocholithiasis and many complications] |
therapeutic application
unassigned |
1
0 |
| 3.4.21.89 | Choledocholithiasis |
10689902 |
[An extremely elderly patient with choledocholithiasis and many complications] |
therapeutic application
unassigned |
1
0 |
| 3.4.21.89 | Chronic Periodontitis |
22798550 |
Identification of a critical bacterial peptidase involved in chronic periodontitis: PG0026 is the C-terminal signal peptidase of a novel secretion system of Porphyromonas gingivalis. |
unassigned |
0 |
| 3.4.21.89 | Classical Swine Fever |
9696875 |
Classical swine fever virus leader proteinase Npro is not required for viral replication in cell culture. |
ongoing research
unassigned |
1
0 |
| 3.4.21.89 | coagulation factor xa deficiency |
8449937 |
Human coagulation factor X deficiency caused by a mutant signal peptide that blocks cleavage by signal peptidase but not targeting and translocation to the endoplasmic reticulum. |
therapeutic application
unassigned |
1
0 |
| 3.4.21.89 | Corneal Injuries |
9224281 |
Pseudomonas deficient in protease IV has significantly reduced corneal virulence. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 3.4.21.89 | Corneal Injuries |
9501882 |
Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. |
causal interaction
therapeutic application
unassigned |
4
3
0 |
